SMS Pharma gets EIR for API facility in Andhra Pradesh; stock slips 4%

The inspection was conducted by the USFDA at its API facility Kandivalasa, Andhra Pradesh, during January 13-17, the company said.

from India Infoline News Service https://ift.tt/2TWFSkh